Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-114524
Filing Date
2025-09-12
Accepted
2025-09-12 16:08:15
Documents
1
Period of Report
2025-09-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A 2025_special_meeting_pre.htm PRE 14A 243316
  Complete submission text file 0000950170-25-114524.txt   244503
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39603 | Film No.: 251311557
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)